Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10212890 | The Annals of Thoracic Surgery | 2018 | 7 Pages |
Abstract
In a large database study, the addition of radiotherapy to adjuvant chemotherapy after resection of N2 NSCLC was not associated with improved survival. Until more definitive data are available, consideration should be given to treating patients with N2 disease detected at resection with adjuvant chemotherapy only.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Justin A. MD, David C. MD, Kurt MD, Benny MD,